Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that it will present ...

In an effort to develop more effective estrogen receptor α (ERα) inhibitors, researchers at Nanjing University of Chinese ...

In this list, we’re highlighting all the best sci-fi games released in 2025. Anything from futuristic puzzle games to ...

Crossfire Oncology BV has divulged proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety covalently linked to a serine/threonine-protein kinase PLK1 (STPK13 ...

Vida Ventures ("Vida"), a next-generation life sciences venture firm, today announced its fourth major Vida portfolio acquisition of 2025, capping an unprecedented year of strategic exits and ...

A new active substance attacks a key protein in tumour cells, leading to complete degradation. In cell experiments, this caused cancer cells to lose their protection and die. The active substance was ...

A few hours after darkness falls during November, the unquestioned landmark of the autumn night sky occupies a commanding ...

When Mary Shelley publishedFrankenstein; or, The Modern Prometheus in 1818, she wasn’t just writing a gothic horror novel—she was laying the foundations for science fiction. Her tale of a scientist ...

Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug recognizes a unique fold in the RNA and triggers the cell to destroy it.

Chimera Investment (CIM) Q3 earnings missed the Wall Street consensus, with the quarter marking a transition for the company as it moved to cash ahead of its HomeXpress acquisition, the company said ...

As any student knows, learning doesn’t always need to be centered on the classroom. Sometimes, you’ve got to take field trips to places where you can see, touch and experience cool exhibits. And if ...